BAFF inhibitors are a class of compounds that target the activity of B-cell Activating Factor (BAFF), a protein primarily involved in regulating the survival, proliferation, and differentiation of B cells. BAFF, a member of the tumor necrosis factor (TNF) superfamily, plays a crucial role in the maturation of B cells, particularly in promoting their survival during various stages of development. Excessive BAFF levels can lead to an overproduction of B cells, which may have unwanted consequences. BAFF inhibitors function by either directly binding to BAFF or interfering with its receptor interactions, thereby modulating the downstream signaling pathways that control B cell homeostasis. By regulating BAFF activity, these inhibitors help maintain a balanced immune system by ensuring the proper regulation of B cell activity.
BAFF inhibitors can vary widely, with some being small molecules, while others are larger, more complex entities. These inhibitors are designed to specifically target BAFF's molecular structure or its receptors on the surface of B cells. The interaction between BAFF and its receptors triggers a cascade of intracellular signaling events that contribute to B cell survival and function, and BAFF inhibitors work by disrupting this signaling process. Through selective inhibition, BAFF inhibitors can effectively regulate B cell populations, preventing excessive or uncontrolled activity. The intricate design and function of BAFF inhibitors demonstrate their critical role in modulating the immune system's response, especially in the context of B cell regulation and signaling pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide may downregulate BAFF by altering the transcriptional machinery, leading to decreased mRNA synthesis for BAFF. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Lenalidomide could decrease the expression of BAFF by hindering the binding of specific transcription factors necessary for BAFF gene transcription. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $143.00 $312.00 $468.00 $1248.00 $1997.00 | 1 | |
Pomalidomide may inhibit the production of BAFF by disrupting the signaling pathways that trigger the synthesis of BAFF mRNA in B cells. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram might reduce BAFF expression by elevating intracellular cAMP levels, which can alter the expression of genes involved in B cell immunity. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
Apigenin could downregulate BAFF transcription by obstructing kinase-driven signaling pathways that promote BAFF gene activation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin might inhibit BAFF expression by directly inhibiting the activation of NF-κB, which directly promotes the transcription of the BAFF gene. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate could reduce BAFF expression by hindering the activation of signaling molecules upstream of NF-κB, leading to a decrease in BAFF promoter activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol might decrease BAFF levels by inhibiting the inflammatory signaling pathways that are responsible for the upregulation of BAFF expression in immune cells. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Hydroxychloroquine could inhibit the synthesis of BAFF by stabilizing lysosomal membranes and thereby preventing the processing of factors required for BAFF expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate might downregulate BAFF by reducing the proliferation of immune cells responsible for BAFF production and by decreasing the stability of BAFF mRNA. | ||||||